Oct 12, 2017 11:05 am UTC| Business
Press release - No. 9/2017 Zealand has initiated a clinical trial to evaluate the potential for less than once-daily dosing with its long-acting GLP-2 analog glepaglutide 30 subjects have already been dosed...
GasLog Partners LP Announces Date for Third-Quarter 2017 Results, Conference Call and Webcast
Oct 12, 2017 11:00 am UTC| Business
Monaco, October 12, 2017, GasLog Partners LP ("GasLog Partners" or the "Partnership") (NYSE: GLOP) today announced that it will release its financial results for the third quarter of 2017 before the market opens on...
Media Alert: QuickLogic CTO to Present at 15th Annual International SoC Conference
Oct 12, 2017 11:00 am UTC| Business
SUNNYVALE, Calif., Oct. 12, 2017 -- QuickLogic Corporation (NASDAQ:QUIK), a developer of ultra-low power multi-core voice-enabled SoCs, embedded FPGA IP, display bridge and programmable logic solutions, announced today...
OrthoPediatrics Corp. Announces Pricing of Initial Public Offering
Oct 12, 2017 11:00 am UTC| Business
WARSAW, Ind., Oct. 12, 2017 -- OrthoPediatrics Corp. (“OrthoPediatrics”), an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market, announced today the...
ZIOPHARM Announces Three Presentations at the 2017 Annual Meeting of the Society for Neuro-Oncology
Oct 12, 2017 11:00 am UTC| Business
BOSTON, Oct. 12, 2017 -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on developing gene and cell-based immunotherapies for cancer, today announced that three abstracts highlighting data...
Oct 12, 2017 11:00 am UTC| Business
ANAVEX2-73 demonstrates desirable PK/PD properties, describing the relationship between drug concentration and the effect observed Anavex is incorporating advanced Artificial Intelligence platform for the analysis of...
Oct 12, 2017 11:00 am UTC| Business
NEW YORK, Oct. 12, 2017 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, announced today...